What is the recommendation for patients at increased ASCVD risk with chronic, stable liver disease?
In patients at increased ASCVD risk with chronic, stable liver disease (including nonalcoholic fatty liver disease) when appropriately indicated, it is reasonable to use statins after obtaining baseline measurements and determining a schedule of monitoring and safety checks. This recommendation is unchanged from the 2018 Cholesterol Guidelines.